SEC Tracker
Get the app
INSP · XBRL financial data

Inspire Medical Systems financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (INSP's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers192,508*164,010195,885203,191239,718*201,317217,086224,501269,077*204,583200,581206,695
Cost of goods and services sold28,054*24,75729,84332,39835,988*30,70934,67231,77336,071*27,67129,12228,837
Gross profit164,454*139,253166,042170,793203,730*170,608182,414192,728233,006*176,912171,459177,858
Research and development31,052*28,85028,85926,08330,336*27,80326,20924,21124,942*25,82624,69822,176
Selling, general and administrativeyear only125,621132,084130,392141,510*144,290159,521158,873161,953*152,204147,275184,398
General and administrative—125,621132,084130,392————————
Total operating expenses155,157*154,471160,943156,475————————
Operating income (loss)9,297*(15,218)5,09914,31831,884*(1,485)(3,316)9,64446,111*(1,118)(514)(28,716)
Interest expense0*—0022*—411122*———
Other income (expense)73*(60)(135)118(778)*578(3,498)(66)330*(226)(110)(191)
Income tax expense (benefit)477*6501,0531,8291,412*1,1671,2603,619(85,771)*13,6912,801(616)
Net income (loss)14,763*(10,005)9,79318,49735,224*2,992(3,592)9,932136,090*(11,294)314(24,394)
Earnings per share, basic USD per share0.50*(0.34)0.330.621.18*0.10(0.12)0.344.70*(0.39)0.01(0.84)
Earnings per share, diluted USD per share0.50*(0.34)0.320.601.12*0.10(0.12)0.344.59*(0.39)0.01(0.84)
Weighted average shares, basic thousands of shares29,517*29,61529,72929,88029,828*29,70229,50729,33228,943*28,70128,83528,929
Weighted average shares, diluted thousands of shares29,517*29,61530,40830,63431,504*30,31129,50729,60029,619*28,70128,94128,929

Balance sheet

CSV

Fiscal quarters (INSP's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents185,537175,416188,035147,512150,15053,882106,927112,845104,81398,932127,761190,803
Short-term investments274,838265,945251,629263,475295,396315,307193,968209,747203,455184,902192,923137,168
Marketable securities274,838265,945251,629263,475295,396315,307193,968209,747203,455184,902192,923137,168
Marketable securities, non-current9,14327,80326,344113,42570,99544,831109,83088,35396,330115,88294,480125,125
Accounts receivable89,88472,33379,71689,74393,06892,628137,687107,989119,692105,088103,340104,706
Inventory33,88548,97459,02567,43280,11899,727121,633141,777145,293166,235170,451178,960
Total current assets593,739572,214607,160582,520630,806571,679573,189586,489583,652566,819608,674627,625
Property and equipment, net39,98452,28161,70167,44771,92577,17585,27491,50697,872100,692104,33085,635
Right-of-use asset22,66722,24822,18921,81123,31424,97224,52424,07023,53223,06822,59922,125
Total assets676,811685,842728,389796,194808,383730,809802,193807,716907,317911,376925,993953,033
Accrued liabilities39,26628,37032,03639,33849,81434,33340,19751,60359,49047,56944,08059,265
Total current liabilities78,10572,17265,65774,26488,50163,47093,359110,84396,05589,41871,18297,338
Lease liability, non-current24,84624,50024,51225,21830,03931,48830,90930,30229,99829,55229,09328,611
Total liabilities104,29796,81890,31899,632118,68895,066124,379141,256126,157119,036100,411126,084
Accumulated deficit(345,423)(355,428)(345,635)(327,138)(291,914)(288,922)(292,514)(282,582)(146,492)(157,786)(157,472)(181,866)
Total stockholders' equity572,514589,024638,071696,562689,695635,743677,814666,460781,160792,340825,582826,949
Total liabilities and equity676,811685,842728,389796,194808,383730,809802,193807,716907,317911,376925,993953,033
Common shares outstanding (cover page) thousands of shares29,58529,71129,82229,96729,66929,49429,57429,05628,58928,81328,91028,966

Cash flows

CSV

Fiscal quarters (INSP's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)14,763*(10,005)9,79318,49735,224*2,992(3,592)9,932136,090*(11,294)314(24,394)
Stock-based compensation22,849*26,32232,30028,20029,140*31,05641,70029,50028,012*30,68931,20026,900
Depreciation and amortization817*8391,383*1,850*2,478*3,0443,414*3,677*3,822*5,1104,597*5,140*
Net cash from operating activities17,267*8,860(78)*52,283*69,181*(6,703)2,684*68,526*52,469*12,84923,228*46,426*
Purchases of property and equipment8,033*11,69612,393*8,007*7,027*8,4078,997*10,439*10,656*9,7269,160*7,542*
Net cash from investing activities(151,723)*(19,535)5,620*(102,968)*3,761*(1,553)46,562*(11,645)*(11,918)*(11,249)3,548*17,048*
Proceeds from issuing common stock0*———year only———————
Share repurchasesyear only00*0*75,000*75,0090*49,999*50,011*00*0*
Repayments of long-term debt0*———year only———————
Net cash from financing activities(10,115)*7687,087*9,890*(70,138)*(87,760)3,697*(51,078)*(48,308)*(7,482)1,911*(436)*
Net change in cash(144,360)*(10,121)12,619*(40,523)*2,638*(96,268)53,045*5,918*(8,032)*(5,881)28,829*63,042*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Inspire Medical Systems190,803206,69546,426*29.0M— 10-QSep 30, 2026
Masimo124,600403,60045,30052.4M— 10-QApr 4, 2026
Integer Holdings14,135449,66136,631*34.0M— 10-QOct 2, 2026
TransMedics Group491,113189,94817,309*34.7M— 10-QJun 30, 2026
Icu Medical298,299551,68380,150*25.0M— 10-QJun 30, 2026
PROCEPT BioRobotics227,91494,498(19,251)*57.3M11.8 quarters 10-QJun 30, 2026
Dentsply Sirona239,000898,00099,000*199.4M— 10-QJun 30, 2026
iRhythm Holdings246,679224,17251,080*33.0M— 10-QJun 30, 2026
Merit Medical Systems503,551416,24465,273*59.9M— 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.